Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:19 AM EDT

Biomea Fusion (BMEA) Asset Writedowns and Impairment (2025)

Biomea Fusion's (BMEA) quarterly Asset Writedowns and Impairment came in at $2.2 million in Q3 2025.

Analysis

Biomea Fusion (BMEA) Asset Writedowns and Impairment (2025) Analysis & Trends

Biomea Fusion has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting $2.2 million for Q3 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Biomea Fusion 132.65 Mn 132.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.21 Mn
API Access

Biomea Fusion Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BMEA&period=max&api_key=YOUR_API_KEY